Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer's‐like signaling in brains of COVID‐19 patients
Steve Reiken, Leah Sittenfeld, Haikel Dridi, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 5, pp. 955-965
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Long COVID: major findings, mechanisms and recommendations
Hannah Davis, Lisa McCorkell, Julia Moore Vogel, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 3, pp. 133-146
Open Access | Times Cited: 2494
Long-term neurologic outcomes of COVID-19
Evan Xu, Yan Xie, Ziyad Al‐Aly
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2406-2415
Open Access | Times Cited: 372
COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study
Chunyu Li, Jiayan Liu, Junyu Lin, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 99
Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model
Christopher Käufer, Cara Sophie Schreiber, Anna-Sophia Hartke, et al.
EBioMedicine (2022) Vol. 79, pp. 103999-103999
Open Access | Times Cited: 72
Cellular and molecular biomarkers of long COVID: a scoping review
Estefanía Espín, Chengliang Yang, Casey P. Shannon, et al.
EBioMedicine (2023) Vol. 91, pp. 104552-104552
Open Access | Times Cited: 59
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 50
New‐onset neurodegenerative diseases as long‐term sequelae of SARS‐CoV‐2 infection: A systematic review and meta‐analysis
Masoud Rahmati, Dong Keon Yon, Seung Won Lee, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Closed Access | Times Cited: 39
Causal effect of COVID‐19 on Alzheimer's disease: A Mendelian randomization study
Ancha Baranova, Hongbao Cao, Fuquan Zhang
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 57
Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients
Michael Fleischer, Fabian Szepanowski, Muriel Tovar, et al.
Neurology and Therapy (2022) Vol. 11, Iss. 4, pp. 1637-1657
Open Access | Times Cited: 50
The COVID-19 pandemic and Alzheimer’s disease: mutual risks and mechanisms
Feng Chen, Yan‐Ting Chen, Yongxiang Wang, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 43
Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview
Anamika Gupta, Hezlin Marzook, Firdos Ahmad
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 2, pp. 313-331
Open Access | Times Cited: 42
Insulin Resistance in Peripheral Tissues and the Brain: A Tale of Two Sites
Elizabeth M. Rhea, William A. Banks, Jacob Raber
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1582-1582
Open Access | Times Cited: 37
Dynamic white matter changes in recovered COVID-19 patients: a two-year follow-up study
Sihong Huang, Xianglin Zhou, Wei Zhao, et al.
Theranostics (2023) Vol. 13, Iss. 2, pp. 724-735
Open Access | Times Cited: 36
Targeting ryanodine receptors to treat human diseases
Andrew R. Marks
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 34
Cortical Grey matter volume depletion links to neurological sequelae in post COVID-19 “long haulers”
Ted L. Rothstein
BMC Neurology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 31
Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
Pei Huang, Linyuan Zhang, Yuyan Tan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Heart failure-induced cognitive dysfunction is mediated by intracellular Ca2+ leak through ryanodine receptor type 2
Haikel Dridi, Yang Liu, Steve Reiken, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 8, pp. 1365-1378
Open Access | Times Cited: 24
Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19
Cameron D. Owens, Camila Bonin Pinto, Sam Detwiler, et al.
Brain Communications (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 10
Viral Infections, Are They a Trigger and Risk Factor of Alzheimer’s Disease?
Meagan D. Rippee‐Brooks, Wenzhe Wu, Jianli Dong, et al.
Pathogens (2024) Vol. 13, Iss. 3, pp. 240-240
Open Access | Times Cited: 10
Do microbes play a role in Alzheimer's disease?
Zoë Williams, Léonie Láng, Sarah Nicolas, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 9
Blood Markers Show Neural Consequences of LongCOVID-19
Norina Tang, Tatsuo Kido, Jian Shi, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 478-478
Open Access | Times Cited: 8
Stress and Inflammation Target Dorsolateral Prefrontal Cortex Function: Neural Mechanisms Underlying Weakened Cognitive Control
Mary Kate P. Joyce, Stacy Uchendu, Amy Arnsten
Biological Psychiatry (2024)
Closed Access | Times Cited: 7
Blood Biomarkers Show Neural Consequences of LongCOVID-19
Norina Tang, Tatsuo Kido, Jian Shi, et al.
(2024)
Open Access | Times Cited: 6
Molecular cross-talk between long COVID-19 and Alzheimer’s disease
Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2885-2899
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top